Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 393085-45-5 | MDL No. : | MFCD04037927 |
Formula : | C8H9NO4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KFOGGDGNOLZBNY-UHFFFAOYSA-N |
M.W : | 215.23 | Pubchem ID : | 2761058 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 50.9 |
TPSA : | 105.84 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.89 cm/s |
Log Po/w (iLOGP) : | 0.49 |
Log Po/w (XLOGP3) : | -0.39 |
Log Po/w (WLOGP) : | 1.46 |
Log Po/w (MLOGP) : | -0.56 |
Log Po/w (SILICOS-IT) : | -0.16 |
Consensus Log Po/w : | 0.17 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.11 |
Solubility : | 16.6 mg/ml ; 0.0769 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.37 |
Solubility : | 9.2 mg/ml ; 0.0427 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.73 |
Solubility : | 3.99 mg/ml ; 0.0185 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 90222-79-0 ]
2-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.96
[ 151104-75-5 ]
3-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.90
[ 90610-65-4 ]
Methyl 2-amino-5-(methylsulfonyl)benzoate
Similarity: 0.89
[ 168618-23-3 ]
Methyl 3-amino-5-(methylsulfonyl)benzoate
Similarity: 0.83
[ 34263-58-6 ]
4-Amino-3-methanesulfonylbenzoic acid
Similarity: 0.82
[ 90222-79-0 ]
2-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.96
[ 151104-75-5 ]
3-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.90
[ 90610-65-4 ]
Methyl 2-amino-5-(methylsulfonyl)benzoate
Similarity: 0.89
[ 168618-23-3 ]
Methyl 3-amino-5-(methylsulfonyl)benzoate
Similarity: 0.83
[ 34263-58-6 ]
4-Amino-3-methanesulfonylbenzoic acid
Similarity: 0.82
[ 90222-79-0 ]
2-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.96
[ 151104-75-5 ]
3-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.90
[ 34263-58-6 ]
4-Amino-3-methanesulfonylbenzoic acid
Similarity: 0.82
[ 1197193-17-1 ]
4-(Methylsulfonyl)-2-pyrrolidinobenzoic Acid
Similarity: 0.80
[ 90222-79-0 ]
2-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.96
[ 151104-75-5 ]
3-Amino-5-(methylsulfonyl)benzoic acid
Similarity: 0.90
[ 90610-65-4 ]
Methyl 2-amino-5-(methylsulfonyl)benzoate
Similarity: 0.89
[ 168618-23-3 ]
Methyl 3-amino-5-(methylsulfonyl)benzoate
Similarity: 0.83
[ 34263-58-6 ]
4-Amino-3-methanesulfonylbenzoic acid
Similarity: 0.82